Business Standard

GlaxoSmithKline Pharma consolidated Q1 net profit rises 11% to Rs 132 cr

Its total income rose to Rs 798 crore in the first quarter against Rs 773 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing

GlaxoSmithKline. Photo: Reuters

GlaxoSmithKline. Photo: Reuters

Press Trust of India New Delhi

Listen to This Article

GlaxoSmithKline Pharmaceuticals on Wednesday said its consolidated net profit increased by 11 per cent to Rs 132 crore for the first quarter ended June 30.
The drug maker had reported a net profit of Rs 119 crore in the April-June quarter of the last fiscal.
Its total income rose to Rs 798 crore in the first quarter against Rs 773 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing.
"Despite the strong external headwinds, GSK remains focused on delivering best-in-class competitive performance and driving operational efficiencies. We remain committed to explore new growth opportunities and improving our leadership in key therapy areas," GlaxoSmithKline Pharmaceuticals MD Bhushan Akshikar said.
Shares of the company were trading 0.3 per cent down at Rs 1,399.20 apiece on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 26 2023 | 3:51 PM IST

Explore News